MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio’s next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio’s ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer’s disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light […]
The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression NEWARK, Calif. — Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and Navinci, an established developer of in situ proximity ligation assay-based solutions, today announced the launch of the Glysite™ Explorer in situ PLA Glycan Detection Kit. The […]
Browse AAA Biotech’s new range of validated antibodies, ELISA kits, and culture media – empowering researchers with high-quality, reliable research reagents. LA JOLLA, CA, UNITED STATES — AAA Biotech, a leader in providing validated research reagents, announces the launch of its suite of validated antibodies, ELISA kits, and culture media. The company reaffirms its commitment to empowering […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of […]
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model Doubles Waters’ total addressable market to approximately $40 billion, with 5-7% annual growth Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases […]
Browse AAA Biotech’s new range of validated antibodies, ELISA kits, and culture media – empowering researchers with high-quality, reliable research reagents. LA JOLLA, CA, UNITED STATES — AAA Biotech, a leader in providing validated research reagents, announces the launch of its suite of validated antibodies, ELISA kits, and culture media. The company reaffirms its commitment […]
MyBioSource’s ELISA kits advance biomedical research, compatible with human, animal, and plant samples. Custom solutions and global shipping are available. SAN DIEGO — MyBioSource, a leading and trusted global supplier of life science research reagents, announces the availability of thousands of ready-to-ship ELISA (Enzyme Linked Immunosorbent Assay) kits produced to accelerate research across a broad […]
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, marking a new chapter in the company’s successful growth story. After nearly 12 years with Tecan, including 6 ½ years as CEO, Dr. Achim von […]
MONHEIM AM RHEIN, Germany — Cube Biotech GmbH today announced the appointment of Dr. Joachim Kreuzburg, former CEO and Chairman of the Executive Board of Sartorius AG, to its Board of Directors, effective July 3rd, 2025. Dr. Kreuzburg brings over two decades of executive leadership in the life sciences industry. During his tenure as CEO of Sartorius (2003–2025), the […]
FREMONT, CA — Biotium, a leading innovator in life science reagents, is proud to support the advancement of super-resolution imaging with the release of their MiniMab™ single-domain antibody (SdAb) series. The MiniMab™ SdAb series, like Nanobodies®, are high-affinity recombinant alpaca VHHs against Glial Fibrillary Acidic Protein (GFAP), Synaptotagmin 1 (SYT1) and Vesicular Glutamate Transporter 1 (VGLUT1). The MiniMab™ SdAbs are expertly […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
